JSM 2012 Home

JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Abstract Details

Activity Number: 343
Type: Contributed
Date/Time: Tuesday, July 31, 2012 : 10:30 AM to 12:20 PM
Sponsor: Biopharmaceutical Section
Abstract - #306754
Title: On the Asymmetrical Margins Approach to Biosimilarity Clinical Trials with Efficacy Endpoints
Author(s): Yulan Li*+ and Qing Liu
Companies: Novartis and Johnson & Johnson
Address: 180 Park Avenue, Florham Park, NJ, 07932, United States
Keywords: Bioequivalence trials ; Immunogenicity ; Lower Predictive Bound ; Non-inferiority Trials ; Retention of effect

Development of biosimilars to innovative therapeutic biologics promises reduction of health care cost, and therefore, provide patients world wide more access to effective treatments. Because of the differences in the raw materials or manufacturing processes, "equivalence" of bioavailability between a biosimilar and the reference biologic is generally insufficient, and clinical trials providing efficacy and safety data are often required by regulatory agencies. Motivated by the World Health Organization (WHO) guideline (2009)and FDA draft guidance (2012), we propose a biosimilarity trial design for evaluating clinical efficacy. The design employs a non-inferiority margin and an asymmetrical non-superiority margin for statistical inference. The choice of both margins provides the scientific foundation for drawing clinical efficacy conclusions while maintaining the logical consistency of the inference. The design also has a higher statistical power than a naive equivalence trial design.

The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.

Back to the full JSM 2012 program

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.